Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Q Biomed Inc (QBIO)

Q Biomed Inc (QBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Patients Demand Personalized Treatments for Cancer as Death Rates Soar

Cancer is ranked among the top causes of death globally, and recent data indicates that the number of cancer related cases is only expected to rise. As a result, the global cancer therapeutics market is...

QBIO : 0.4742 (-7.02%)
ABBV : 75.14 (+0.52%)
SGEN : 85.94 (+2.48%)
MRK : 83.80 (-0.77%)
GSK : 42.47 (+0.45%)
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement for its non-opioid metastatic cancer pallion drug, Strontium-89...

QBIO : 0.4742 (-7.02%)
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States

NEW YORK , Oct. 3, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, announced today it has entered into an exclusive distribution agreement...

QBIO : 0.4742 (-7.02%)
Q BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain Drug

Q BioMed Inc. (OTCQB: QBIO), is pleased to report that it has entered into a settlement agreement with BioNucleonics Inc. to complete the outright acquisition of the non-opioid cancer bone pain drug Strontium-89...

QBIO : 0.4742 (-7.02%)
Q BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain Drug

NEW YORK , Oct. 2, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO),  is pleased to report that it has entered into a settlement agreement with BioNucleonics Inc. to complete the outright acquisition...

QBIO : 0.4742 (-7.02%)
Q Biomed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic

Q BioMed, Inc. (OTCQB: QBIO) and Chemveda Life Sciences are very pleased to announce that after the recent successful chemical synthesis of a unique natural compound that has shown remarkable efficacy...

QBIO : 0.4742 (-7.02%)
Q Biomed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic

QBIO : 0.4742 (-7.02%)
Q BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver Cancer

Q BioMed, Inc. (OTCQB: QBIO) and Chemveda Life Sciences are very pleased to announce the successful chemical synthesis of a unique natural compound that has shown remarkable efficacy as a potential chemotherapy...

QBIO : 0.4742 (-7.02%)
Q BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver Cancer

NEW YORK , Aug. 20, 2019 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) and  Chemveda Life Sciences are very pleased to announce the successful chemical synthesis of a unique natural compound...

QBIO : 0.4742 (-7.02%)
Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity

New York, New York--(Newsfile Corp. - June 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities...

QBIO : 0.4742 (-7.02%)
Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments

According to the Centers for Disease Control, autism affects an estimated 1 in 59 children in the United States today. The Autism Speaks website defines the main problem for researchers/practitioners...

QBIO : 0.4742 (-7.02%)
PHAS : 4.04 (+2.02%)
INSM : 17.53 (-0.17%)
CMRX : 1.43 (-5.30%)
GERN : 1.49 (+0.68%)
Q BioMed's Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma Sufferers

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 0.4742 (-7.02%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

ACRGF : 6.0800 (+2.01%)
ALEAF : 0.6600 (+7.93%)
ARREF : 0.5451 (+17.23%)
CWBHF : 13.6505 (+2.25%)
CORVF : 1.4800 (+4.23%)
CRLBF : 6.5600 (+1.23%)
DYAI : 6.53 (-1.51%)
ELLXF : 1.4445 (-0.03%)
EMHTF : 0.7570 (+13.14%)
GLDLF : 0.7652 (-2.45%)
GTBIF : 9.5000 (+2.14%)
GRWG : 3.9700 (+3.39%)
HEOFF : 0.9448 (+2.70%)
ITHUF : 1.5300 (+4.79%)
IMLFF : 0.2106 (+1.30%)
ISYRF : 1.1500 (+9.92%)
MMNFF : 1.0400 (-4.59%)
MTAFF : 1.0650 (+4.00%)
MJARF : 0.4200 (+28.99%)
NUPMF : 3.4268 (+2.94%)
NLST : 0.3440 (-1.15%)
STLHF : 0.5200 (-8.50%)
TRLFF : 0.1490 (+15.68%)
AITB : 5.24 (+2.34%)
ALYE : 2.5550 (-5.37%)
ARTH : 0.1585 (-20.75%)
ARHH : 1.2800 (+3.23%)
ATEA : 11.4500 (+0.44%)
BICXD : 4.5400 (-9.02%)
BRTI : 0.2100 (+10.53%)
CNBX : 0.2200 (+4.12%)
CLOK : 0.7700 (-14.44%)
CVSI : 2.1000 (+11.70%)
DUOT : 0.4700 (+1.08%)
EVLLF : 0.9200 (-1.08%)
FLUX : 9.8000 (+0.51%)
GBPT : 7.0000 (-12.50%)
GTBP : 0.1500 (-13.29%)
KSHB : 1.3560 (-3.14%)
MRMD : 0.6989 (-0.16%)
MLCPF : 3.5200 (+11.47%)
MRIC : 4.26 (-6.37%)
NMUS : 0.6500 (-9.52%)
NWGI : 0.4200 (+1.20%)
OWCP : 0.0084 (-6.67%)
PPCB : 0.8600 (-3.37%)
QBIO : 0.4742 (-7.02%)
RSSS : 2.4100 (-1.23%)
VTLR : 0.0510 (-11.30%)
WIZD : 0.0900 (-2.70%)
OTCM : 34.3500 (-2.64%)
Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 0.4742 (-7.02%)
Demand for New Glaucoma Therapies Has Greatest Potential to Drive Value for Q BioMed's Shareholders

NEW YORK, NY / ACCESSWIRE / February 8, 2019 / Q BioMed (OTCQB: QBIO) has announced that it is bringing innovation to the treatment of Glaucoma- the the leading cause of irreversible blindness globally....

QBIO : 0.4742 (-7.02%)
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity

Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities undertaken by the Company.

QBIO : 0.4742 (-7.02%)
Biotech Companies Introduce New Treatments as Concern Over Cancer Rises

Cancer is among one of the leading causes of death around the globe; namely, in 2018, there were a total estimated 18.1 million new cases worldwide. The International Agency for Research on Cancer (IARC)...

CELGZ : 0.47 (+5.30%)
QBIO : 0.4742 (-7.02%)
CELG : 101.80 (+0.82%)
SGEN : 85.94 (+2.48%)
INCY : 77.43 (-0.88%)
NKTR : 17.77 (+1.31%)
Biotechnology Companies See Growth in Optic Treatment Sectors

The vast number of people in need of medical treatment has grown tremendously over the years. Some cases are a result of environmental changes, yet others can be caused by genetics. Regardless, there is...

QBIO : 0.4742 (-7.02%)
NVS : 87.23 (+0.26%)
AERI : 21.25 (+2.31%)
AXSM : 22.52 (+4.11%)
VSTM : 1.13 (+0.89%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

NEW YORK , Feb. 5, 2019 /PRNewswire/ --  www.FinancialBuzz.com , a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with...

QBIO : 0.4742 (-7.02%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

www.FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Q Biomed Inc. (OTCQB: QBIO) Chairman and CEO, Denis...

TPIV : 8.34 (+0.60%)
QBIO : 0.4742 (-7.02%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +4.89 , AIZ +0.49 , SBAC +7.10 , SO -0.03 , WELL +0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar